US Stock MarketDetailed Quotes

ELEV Elevation Oncology

Watchlist
  • 0.627
  • +0.001+0.14%
Trading Nov 27 13:16 ET
37.06MMarket Cap-783P/E (TTM)

Elevation Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
37.25%-8.38M
40.59%-8.21M
43.11%-9.58M
34.28%-56.18M
31.76%-12.18M
69.77%-13.36M
-46.50%-13.81M
-20.02%-16.83M
-183.37%-85.48M
-100.24%-17.85M
Net income from continuing operations
-21.11%-12.88M
-3.47%-10.46M
37.24%-10.71M
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
-196.76%-95.08M
-97.90%-19.04M
Operating gains losses
--0
--0
--942K
----
----
----
----
----
----
----
Depreciation and amortization
-44.44%5K
-60.00%4K
0.00%10K
44.44%39K
0.00%10K
12.50%9K
100.00%10K
150.00%10K
50.00%27K
100.00%10K
Other non cash items
-41.67%105K
-37.79%107K
-2.42%161K
146.32%702K
10.78%185K
--180K
--172K
--165K
--285K
--167K
Change In working capital
203.52%3.67M
131.38%1.45M
51.91%-605K
-317.65%-13.69M
-1,380.84%-4.28M
43.76%-3.55M
-147.67%-4.61M
-148.25%-1.26M
2,122.61%6.29M
2,285.71%334K
-Change in prepaid assets
118.57%509K
94.53%996K
36.07%1.23M
-251.31%-2.14M
-215.89%-815K
-18.40%-2.74M
-48.95%512K
-6.15%901K
64.58%-610K
-348.08%-258K
-Change in payables and accrued expense
491.71%3.17M
108.77%449K
15.19%-1.83M
-267.35%-11.55M
-684.97%-3.46M
79.78%-808K
-159.11%-5.12M
-231.09%-2.16M
244.14%6.9M
757.78%592K
Cash from discontinued investing activities
Operating cash flow
37.25%-8.38M
40.59%-8.21M
43.11%-9.58M
34.28%-56.18M
31.76%-12.18M
69.77%-13.36M
-46.50%-13.81M
-20.02%-16.83M
-183.37%-85.48M
-100.24%-17.85M
Investing cash flow
Cash flow from continuing investing activities
92.46%-2.87M
-328.24%-37.66M
-22.18%20.7M
126.00%11.54M
-41.33%6.56M
-385.18%-38.12M
59.79%16.5M
133.56%26.6M
-44.4M
11.18M
Net PPE purchase and sale
----
----
----
--0
----
----
----
----
---86K
--0
Net investment purchase and sale
92.46%-2.87M
-328.24%-37.66M
-22.18%20.7M
126.05%11.54M
-41.33%6.56M
-383.36%-38.12M
59.79%16.5M
133.56%26.6M
---44.31M
--11.18M
Cash from discontinued investing activities
Investing cash flow
92.46%-2.87M
-328.24%-37.66M
-22.18%20.7M
126.00%11.54M
-41.33%6.56M
-385.18%-38.12M
59.79%16.5M
133.56%26.6M
---44.4M
--11.18M
Financing cash flow
Cash flow from continuing financing activities
-62.96%10K
-69.24%14.68M
13,904.63%30.25M
62.55%47.98M
50.00%-2K
-99.91%27K
191,036.00%47.73M
1,036.84%216K
-69.59%29.51M
-4K
Net issuance payments of debt
----
----
----
--0
----
----
----
----
--30M
--0
Net common stock issuance
33.33%-2K
-68.74%14.54M
247,016.67%29.63M
132,897.14%46.48M
50.00%-2K
50.00%-3K
186,084.00%46.5M
---12K
-100.04%-35K
---4K
Proceeds from stock option exercised by employees
-60.00%12K
-86.51%167K
237.72%770K
7,773.68%1.5M
--0
--30K
--1.24M
1,100.00%228K
--19K
--0
Net other financing activities
--0
---20K
---150K
----
----
----
----
----
-4,172.73%-470K
--0
Cash from discontinued financing activities
Financing cash flow
-62.96%10K
-69.24%14.68M
13,904.63%30.25M
62.55%47.98M
50.00%-2K
-99.91%27K
191,036.00%47.73M
1,036.84%216K
-69.59%29.51M
---4K
Net cash flow
Beginning cash position
-44.09%59.45M
62.12%90.63M
7.27%49.26M
-68.61%45.92M
4.35%54.88M
97.33%106.33M
5.46%55.9M
-68.61%45.92M
84.24%146.28M
-66.11%52.59M
Current changes in cash
78.14%-11.25M
-161.84%-31.18M
314.37%41.38M
103.33%3.34M
15.72%-5.62M
-3,878.89%-51.45M
5,669.22%50.42M
110.70%9.99M
-250.06%-100.37M
25.15%-6.67M
End cash Position
-12.17%48.2M
-44.09%59.45M
62.12%90.63M
7.27%49.26M
7.27%49.26M
4.35%54.88M
97.33%106.33M
5.46%55.9M
-68.61%45.92M
-68.61%45.92M
Free cash flow
37.25%-8.38M
40.59%-8.21M
43.11%-9.58M
34.35%-56.18M
31.76%-12.18M
69.83%-13.36M
-46.50%-13.81M
-20.02%-16.83M
-183.65%-85.57M
-100.24%-17.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 37.25%-8.38M40.59%-8.21M43.11%-9.58M34.28%-56.18M31.76%-12.18M69.77%-13.36M-46.50%-13.81M-20.02%-16.83M-183.37%-85.48M-100.24%-17.85M
Net income from continuing operations -21.11%-12.88M-3.47%-10.46M37.24%-10.71M51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M-196.76%-95.08M-97.90%-19.04M
Operating gains losses --0--0--942K----------------------------
Depreciation and amortization -44.44%5K-60.00%4K0.00%10K44.44%39K0.00%10K12.50%9K100.00%10K150.00%10K50.00%27K100.00%10K
Other non cash items -41.67%105K-37.79%107K-2.42%161K146.32%702K10.78%185K--180K--172K--165K--285K--167K
Change In working capital 203.52%3.67M131.38%1.45M51.91%-605K-317.65%-13.69M-1,380.84%-4.28M43.76%-3.55M-147.67%-4.61M-148.25%-1.26M2,122.61%6.29M2,285.71%334K
-Change in prepaid assets 118.57%509K94.53%996K36.07%1.23M-251.31%-2.14M-215.89%-815K-18.40%-2.74M-48.95%512K-6.15%901K64.58%-610K-348.08%-258K
-Change in payables and accrued expense 491.71%3.17M108.77%449K15.19%-1.83M-267.35%-11.55M-684.97%-3.46M79.78%-808K-159.11%-5.12M-231.09%-2.16M244.14%6.9M757.78%592K
Cash from discontinued investing activities
Operating cash flow 37.25%-8.38M40.59%-8.21M43.11%-9.58M34.28%-56.18M31.76%-12.18M69.77%-13.36M-46.50%-13.81M-20.02%-16.83M-183.37%-85.48M-100.24%-17.85M
Investing cash flow
Cash flow from continuing investing activities 92.46%-2.87M-328.24%-37.66M-22.18%20.7M126.00%11.54M-41.33%6.56M-385.18%-38.12M59.79%16.5M133.56%26.6M-44.4M11.18M
Net PPE purchase and sale --------------0-------------------86K--0
Net investment purchase and sale 92.46%-2.87M-328.24%-37.66M-22.18%20.7M126.05%11.54M-41.33%6.56M-383.36%-38.12M59.79%16.5M133.56%26.6M---44.31M--11.18M
Cash from discontinued investing activities
Investing cash flow 92.46%-2.87M-328.24%-37.66M-22.18%20.7M126.00%11.54M-41.33%6.56M-385.18%-38.12M59.79%16.5M133.56%26.6M---44.4M--11.18M
Financing cash flow
Cash flow from continuing financing activities -62.96%10K-69.24%14.68M13,904.63%30.25M62.55%47.98M50.00%-2K-99.91%27K191,036.00%47.73M1,036.84%216K-69.59%29.51M-4K
Net issuance payments of debt --------------0------------------30M--0
Net common stock issuance 33.33%-2K-68.74%14.54M247,016.67%29.63M132,897.14%46.48M50.00%-2K50.00%-3K186,084.00%46.5M---12K-100.04%-35K---4K
Proceeds from stock option exercised by employees -60.00%12K-86.51%167K237.72%770K7,773.68%1.5M--0--30K--1.24M1,100.00%228K--19K--0
Net other financing activities --0---20K---150K---------------------4,172.73%-470K--0
Cash from discontinued financing activities
Financing cash flow -62.96%10K-69.24%14.68M13,904.63%30.25M62.55%47.98M50.00%-2K-99.91%27K191,036.00%47.73M1,036.84%216K-69.59%29.51M---4K
Net cash flow
Beginning cash position -44.09%59.45M62.12%90.63M7.27%49.26M-68.61%45.92M4.35%54.88M97.33%106.33M5.46%55.9M-68.61%45.92M84.24%146.28M-66.11%52.59M
Current changes in cash 78.14%-11.25M-161.84%-31.18M314.37%41.38M103.33%3.34M15.72%-5.62M-3,878.89%-51.45M5,669.22%50.42M110.70%9.99M-250.06%-100.37M25.15%-6.67M
End cash Position -12.17%48.2M-44.09%59.45M62.12%90.63M7.27%49.26M7.27%49.26M4.35%54.88M97.33%106.33M5.46%55.9M-68.61%45.92M-68.61%45.92M
Free cash flow 37.25%-8.38M40.59%-8.21M43.11%-9.58M34.35%-56.18M31.76%-12.18M69.83%-13.36M-46.50%-13.81M-20.02%-16.83M-183.65%-85.57M-100.24%-17.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data